These predispositions, interpreted alongside clinical biomarkers and provider assessment, may help frame why certain individuals show stronger appetite suppression or weight loss trajectoriesinforming more targeted treatment conversations rather than guesswork
This sustained usage could have lasting implications for brands, as additional data reveal shifts in daily habits
Informed consents were obtained from the patients or their proxies and study was conducted according to protocols and methods approved by the local Institutional Review Board
Next Steps in Research: Recommendations From PWS Experts A recent collaborative workshop hosted by the Foundation for Prader-Willi Research (FPWR) and the International Prader-Willi Syndrome Organisation (IPWSO), and led by Drs
S2, S3 and S4 in the ESM)
Berberine is not a magic bullet, but research shows it can be a helpful tool when used under the guidance of a healthcare provider